CVS, CMCSA, META, NCLH and more

Check out the companies making the biggest moves in premarket trading: CVS Health — The stock popped 7% after the drugstore chain reported an earnings and revenue beat for its second quarter. The company also boosted its adjusted profit outlook, now expecting a range of $6.30 to $6.40 per share for fiscal 2025, up from…

Read More

Schizophrenia drug Cobenfy could treat Alzheimer’s

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023.  Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb believes Alzheimer’s is the largest market for its newly approved schizophrenia drug, Cobenfy, which it expects to eventually generate billions of dollars in revenue. In…

Read More